Val-Ala-PAB
CAS No. 1343476-44-7
Val-Ala-PAB( —— )
Catalog No. M23503 CAS No. 1343476-44-7
Val-Ala-PAB is a building block in the synthesis of Tesirine (a.k.a. SG3249), a clinical antibody-drug conjugate pyrrolobenzodiazepine dimer payload.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 51 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 40 | In Stock |
|
| 25MG | 64 | In Stock |
|
| 50MG | 91 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVal-Ala-PAB
-
NoteResearch use only, not for human use.
-
Brief DescriptionVal-Ala-PAB is a building block in the synthesis of Tesirine (a.k.a. SG3249), a clinical antibody-drug conjugate pyrrolobenzodiazepine dimer payload.
-
DescriptionVal-Ala-PAB is a building block in the synthesis of Tesirine (a.k.a. SG3249), a clinical antibody-drug conjugate pyrrolobenzodiazepine dimer payload. Reagent in the preparation of pyrrolobenzodiazepine dimers and their antibody conjugates containing peptide linkers useful for treating proliferative including cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1343476-44-7
-
Formula Weight293.36
-
Molecular FormulaC15H23N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)[C@@H](C(N[C@@H](C)C(Nc1ccc(CO)cc1)=O)=O)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Apigenin 5-O-beta-D-...
Apigenin 5-O-beta-D-glucopyranoside has inhibitory activity against the enzyme yeast a-glucosidase, withthe IC50 value of 287.12 muM.
-
Dibutyl sebacate
Dibutyl sebacate is an organic chemical which is mainly used as a plasticizer in the production of plastics.
-
Lufotrelvir
Lufotrelvir (PF-07304814) is a small molecule inhibitor of the SARS CoV-2 3CL protease for the treatment of COVID-19 with broad-spectrum anti-SARS activity for the study of novel coronavirus infections.
Cart
sales@molnova.com